| Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity SE Mastenbroek, A Sala, D Vállez García, M Shekari, G Salvadó, ... Neurology 103 (1), e209419, 2024 | | 2024 |
| Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease A Gómez-Pascual, T Naccache, J Xu, K Hooshmand, A Wretlind, ... Computers in Biology and Medicine 176, 108588, 2024 | 1 | 2024 |
| Post‐GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3 DJ Panyard, LM Reus, M Ali, J Liu, YK Deming, Q Lu, G Kollmorgen, ... Alzheimer's & Dementia, 2024 | | 2024 |
| The clinical importance of suspected non-Alzheimer disease pathophysiology SJB Vos, A Delvenne, CR Jack Jr, DR Thal, PJ Visser Nature Reviews Neurology, 1-10, 2024 | | 2024 |
| Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study A Bollack, LE Collij, DV García, M Shekari, D Altomare, P Payoux, ... Alzheimer's & Dementia 20 (5), 3429-3441, 2024 | | 2024 |
| Feasibility and usability of remote monitoring in Alzheimer's disease M Muurling, C de Boer, C Hinds, A Atreya, A Doherty, V Alepopoulos, ... Digital health 10, 20552076241238133, 2024 | | 2024 |
| Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia LM Reus, IE Jansen, BM Tijms, PJ Visser, N Tesi, SJ van der Lee, ... Brain, awae090, 2024 | | 2024 |
| Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies EL Twait, M Kamarioti, IMW Verberk, CE Teunissen, ACJ Nooyens, ... The American Journal of Geriatric Psychiatry, 2024 | | 2024 |
| Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project K Malzbender, P Barbarino, PB Ferrell, A Bradshaw, AJ Brookes, C Díaz, ... The Journal of Prevention of Alzheimer's Disease 11 (2), 329-338, 2024 | 2 | 2024 |
| Contributions of amyloid beta and cerebral small vessel disease in clinical decline JEF Moonen, R Haan, I Bos, C Teunissen, E Van de Giessen, ... Alzheimer's & Dementia 20 (3), 1868-1880, 2024 | 1 | 2024 |
| People get ready! A new generation of Alzheimer's therapies may require new ways to deliver and pay for healthcare K Wahlberg, B Winblad, A Cole, WL Herring, J Ramsberg, I Torontali, ... Journal of Internal Medicine 295 (3), 281-291, 2024 | 2 | 2024 |
| The association of glucose metabolism measures and diabetes status with Alzheimer’s disease biomarkers of amyloid and tau: a systematic review and meta-analysis V van Gils, M Rizzo, J Côte, W Viechtbauer, G Fanelli, J Salas-Salvadó, ... Neuroscience & Biobehavioral Reviews, 105604, 2024 | | 2024 |
| Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: The SMART‐MR Study EL Twait, L Gerritsen, JEF Moonen, IMW Verberk, CE Teunissen, ... Journal of the American Heart Association, e032134, 2024 | 1 | 2024 |
| Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles BM Tijms, EM Vromen, O Mjaavatten, H Holstege, LM Reus, ... Nature aging, 1-15, 2024 | 28 | 2024 |
| Uncovering social states in healthy and clinical populations using digital phenotyping and Hidden Markov Models IE Leaning, A Costanzo, R Jagesar, LM Reus, PJ Visser, MJH Kas, ... medRxiv, 2024.06. 07.24308598, 2024 | | 2024 |
| Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease M Muurling, C de Boer, S Vairavan, RL Harms, AS Chadha, I Tarnanas, ... NPJ digital medicine 6 (1), 234, 2023 | 2 | 2023 |
| Longitudinal cerebrospinal fluid measurements show glial hypo-and hyperactivation in predementia Alzheimer’s disease K Nordengen, BE Kirsebom, G Richter, L Pålhaugen, B Gísladóttir, ... Journal of neuroinflammation 20 (1), 298, 2023 | | 2023 |
| TREM2‐related Polygenic Risk Score predicts defect Innate Immune Activation in Alzheimer’s Disease JIR Dijkstra, BM Tijms, L Vermunt, CE Teunissen, WM Flier, H Holstege, ... Alzheimer's & Dementia 19, e078378, 2023 | | 2023 |
| Hyperspectral retinal imaging as a biomarker for Alzheimer’s disease M Thach, FJH de Ruyter, KR Curro‐Tafili, E van de Giessen, LE Collij, ... Alzheimer's & Dementia 19, e079569, 2023 | | 2023 |
| Efficacy results from the unique long‐term randomised controlled double‐blind LipiDiDiet trial with a multinutrient intervention in prodromal AD/MCI_AD T Hartmann, A Solomon, PJ Visser, FM van Oudenhoven, K Blennow, ... Alzheimer's & Dementia 19, e078513, 2023 | | 2023 |
